United Therapeutics Corp
NASDAQ:UTHR
Balance Sheet
Balance Sheet Decomposition
United Therapeutics Corp
United Therapeutics Corp
Balance Sheet
United Therapeutics Corp
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
123
|
68
|
83
|
69
|
91
|
139
|
130
|
100
|
252
|
163
|
154
|
284
|
398
|
832
|
1 023
|
705
|
669
|
738
|
739
|
895
|
961
|
1 208
|
1 697
|
1 557
|
|
| Cash Equivalents |
123
|
68
|
83
|
69
|
91
|
139
|
130
|
100
|
252
|
163
|
154
|
284
|
398
|
832
|
1 023
|
705
|
669
|
738
|
739
|
895
|
961
|
1 208
|
1 697
|
1 557
|
|
| Short-Term Investments |
0
|
0
|
0
|
56
|
137
|
151
|
107
|
129
|
375
|
241
|
325
|
410
|
298
|
122
|
28
|
222
|
747
|
748
|
1 096
|
1 036
|
1 878
|
1 786
|
1 570
|
1 363
|
|
| Total Receivables |
10
|
11
|
16
|
19
|
26
|
30
|
31
|
53
|
74
|
89
|
117
|
126
|
162
|
193
|
215
|
297
|
176
|
151
|
157
|
199
|
220
|
279
|
279
|
350
|
|
| Accounts Receivables |
10
|
10
|
14
|
14
|
23
|
26
|
28
|
51
|
74
|
89
|
117
|
126
|
162
|
193
|
215
|
297
|
176
|
151
|
157
|
199
|
220
|
279
|
279
|
350
|
|
| Other Receivables |
0
|
1
|
2
|
5
|
3
|
4
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
7
|
8
|
8
|
11
|
12
|
13
|
14
|
26
|
36
|
46
|
37
|
48
|
67
|
81
|
100
|
108
|
101
|
93
|
87
|
94
|
102
|
112
|
158
|
183
|
|
| Other Current Assets |
2
|
2
|
4
|
11
|
12
|
20
|
16
|
15
|
28
|
24
|
35
|
46
|
49
|
47
|
60
|
116
|
75
|
134
|
88
|
100
|
219
|
166
|
170
|
249
|
|
| Total Current Assets |
142
|
90
|
111
|
167
|
277
|
353
|
297
|
325
|
765
|
563
|
669
|
914
|
974
|
1 275
|
1 425
|
1 448
|
1 768
|
1 865
|
2 167
|
2 324
|
3 380
|
3 551
|
3 874
|
3 703
|
|
| PP&E Net |
9
|
15
|
18
|
22
|
35
|
69
|
223
|
304
|
306
|
366
|
454
|
465
|
478
|
496
|
489
|
546
|
700
|
743
|
732
|
781
|
862
|
1 045
|
1 222
|
1 730
|
|
| PP&E Gross |
9
|
15
|
18
|
22
|
35
|
69
|
223
|
304
|
306
|
366
|
454
|
465
|
478
|
496
|
489
|
546
|
700
|
743
|
732
|
781
|
862
|
1 045
|
1 222
|
1 730
|
|
| Accumulated Depreciation |
3
|
4
|
6
|
8
|
9
|
10
|
14
|
23
|
38
|
53
|
78
|
106
|
135
|
155
|
175
|
203
|
235
|
269
|
309
|
342
|
383
|
428
|
491
|
568
|
|
| Intangible Assets |
7
|
6
|
6
|
6
|
3
|
1
|
0
|
10
|
7
|
14
|
6
|
3
|
19
|
18
|
24
|
32
|
139
|
130
|
130
|
17
|
17
|
81
|
80
|
84
|
|
| Goodwill |
8
|
8
|
8
|
8
|
8
|
8
|
8
|
9
|
3
|
8
|
11
|
11
|
10
|
10
|
10
|
14
|
32
|
28
|
28
|
28
|
28
|
34
|
32
|
32
|
|
| Note Receivable |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
17
|
56
|
54
|
53
|
41
|
10
|
100
|
149
|
133
|
344
|
306
|
448
|
123
|
38
|
2
|
503
|
443
|
768
|
1 150
|
1 650
|
1 316
|
1 938
|
1 534
|
1 831
|
|
| Other Long-Term Assets |
2
|
3
|
11
|
37
|
113
|
147
|
246
|
256
|
218
|
224
|
182
|
246
|
280
|
347
|
375
|
338
|
320
|
380
|
409
|
370
|
442
|
518
|
622
|
501
|
|
| Other Assets |
8
|
8
|
8
|
8
|
8
|
8
|
8
|
9
|
3
|
8
|
11
|
11
|
10
|
10
|
10
|
14
|
32
|
28
|
28
|
28
|
28
|
34
|
32
|
32
|
|
| Total Assets |
185
N/A
|
180
-3%
|
207
+15%
|
291
+41%
|
477
+64%
|
587
+23%
|
875
+49%
|
1 052
+20%
|
1 432
+36%
|
1 518
+6%
|
1 627
+7%
|
2 088
+28%
|
1 884
-10%
|
2 184
+16%
|
2 326
+6%
|
2 879
+24%
|
3 401
+18%
|
3 913
+15%
|
4 615
+18%
|
5 169
+12%
|
6 045
+17%
|
7 167
+19%
|
7 364
+3%
|
7 880
+7%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
5
|
4
|
6
|
4
|
3
|
2
|
20
|
19
|
16
|
47
|
10
|
7
|
7
|
8
|
8
|
8
|
23
|
10
|
4
|
4
|
4
|
6
|
6
|
7
|
|
| Accrued Liabilities |
5
|
6
|
8
|
10
|
15
|
18
|
21
|
30
|
50
|
57
|
68
|
80
|
71
|
88
|
96
|
163
|
143
|
140
|
183
|
171
|
226
|
292
|
339
|
481
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
220
|
236
|
0
|
1
|
283
|
127
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
0
|
0
|
0
|
250
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
250
|
0
|
0
|
0
|
400
|
300
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
3
|
17
|
61
|
126
|
108
|
97
|
319
|
300
|
340
|
228
|
274
|
111
|
63
|
136
|
131
|
113
|
106
|
94
|
73
|
|
| Total Current Liabilities |
9
|
11
|
14
|
15
|
19
|
273
|
58
|
330
|
429
|
213
|
177
|
688
|
504
|
441
|
333
|
445
|
277
|
463
|
323
|
305
|
343
|
804
|
738
|
561
|
|
| Long-Term Debt |
2
|
0
|
0
|
0
|
250
|
0
|
235
|
30
|
69
|
266
|
275
|
0
|
0
|
0
|
0
|
250
|
250
|
600
|
800
|
800
|
800
|
300
|
0
|
0
|
|
| Other Liabilities |
2
|
1
|
2
|
2
|
3
|
8
|
16
|
27
|
39
|
81
|
80
|
96
|
115
|
144
|
131
|
64
|
67
|
70
|
97
|
105
|
105
|
78
|
182
|
223
|
|
| Total Liabilities |
13
N/A
|
12
-9%
|
16
+32%
|
16
+5%
|
272
+1 571%
|
280
+3%
|
308
+10%
|
388
+26%
|
537
+38%
|
559
+4%
|
532
-5%
|
783
+47%
|
619
-21%
|
585
-5%
|
463
-21%
|
758
+64%
|
593
-22%
|
1 133
+91%
|
1 220
+8%
|
1 210
-1%
|
1 248
+3%
|
1 182
-5%
|
920
-22%
|
784
-15%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
186
|
196
|
180
|
115
|
41
|
22
|
94
|
75
|
31
|
249
|
554
|
728
|
1 068
|
1 720
|
2 434
|
2 846
|
3 435
|
3 325
|
3 839
|
4 315
|
5 042
|
6 027
|
7 222
|
8 557
|
|
| Additional Paid In Capital |
364
|
369
|
376
|
394
|
409
|
548
|
722
|
799
|
929
|
993
|
1 016
|
1 057
|
1 376
|
1 791
|
1 814
|
1 854
|
1 940
|
2 048
|
2 149
|
2 245
|
2 388
|
2 549
|
2 699
|
2 798
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
4
|
10
|
5
|
56
|
11
|
1
|
11
|
|
| Treasury Stock |
7
|
7
|
7
|
7
|
165
|
232
|
67
|
67
|
67
|
283
|
471
|
513
|
1 186
|
1 902
|
2 380
|
2 579
|
2 579
|
2 579
|
2 579
|
2 579
|
2 579
|
2 579
|
3 475
|
4 260
|
|
| Other Equity |
0
|
2
|
3
|
4
|
2
|
11
|
5
|
7
|
2
|
0
|
4
|
32
|
6
|
9
|
6
|
2
|
14
|
18
|
25
|
18
|
1
|
2
|
5
|
10
|
|
| Total Equity |
172
N/A
|
168
-2%
|
192
+14%
|
275
+44%
|
205
-26%
|
307
+50%
|
566
+85%
|
664
+17%
|
895
+35%
|
959
+7%
|
1 095
+14%
|
1 304
+19%
|
1 266
-3%
|
1 600
+26%
|
1 862
+16%
|
2 121
+14%
|
2 808
+32%
|
2 780
-1%
|
3 395
+22%
|
3 959
+17%
|
4 797
+21%
|
5 985
+25%
|
6 444
+8%
|
7 096
+10%
|
|
| Total Liabilities & Equity |
185
N/A
|
180
-3%
|
207
+15%
|
291
+41%
|
477
+64%
|
587
+23%
|
875
+49%
|
1 052
+20%
|
1 432
+36%
|
1 518
+6%
|
1 627
+7%
|
2 088
+28%
|
1 884
-10%
|
2 184
+16%
|
2 326
+6%
|
2 879
+24%
|
3 401
+18%
|
3 913
+15%
|
4 615
+18%
|
5 169
+12%
|
6 045
+17%
|
7 167
+19%
|
7 364
+3%
|
7 880
+7%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
42
|
43
|
45
|
47
|
43
|
45
|
53
|
54
|
58
|
54
|
50
|
50
|
47
|
46
|
43
|
43
|
44
|
44
|
45
|
45
|
46
|
47
|
45
|
44
|
|